CHE (Roto-Rooter) רווח נקי למניה ב-12 החודשים האחרונים
Despite wage inflation pressure and healthcare staffing shortages, the trailing 12-month EPS demonstrates resilience, with 21.03 representing the current level of the metric. This chart confirms the effectiveness of the hospice acquisition strategy funded by revenues from the plumbing service. The success of Chemed Corporation (CHE) is based on inelastic demand in both niches, which guarantees high margins.
%20%D7%A8%D7%95%D7%95%D7%97%20%D7%9C%D7%9E%D7%A0%D7%99%D7%94%20%D7%9C%D7%A9%D7%A0%D7%94%20%D7%9E%D7%AA%D7%92%D7%9C%D7%92%D7%9C%D7%AA&width=1200&height=400&colorIndex=0&v=mwhdatcg.m7-7dqbc3k&start=20220704&end=20261115&filename=GURU_Markets_-_CHE_-_Chemed-Corporation_-_Earnings-per-share-for-the-trailing-year "CHE - רווח נקי למניה (EPS TTM) Chemed Corporation בטווח 04.07.2022 - 15.11.2026 | 👁️GURU.Markets👁️")
פילוחים אנליטיים של חברת Chemed Corp (CHE)
This metric reflects the actual equity value of the business, dividing total annual net income by the total number of shares to evaluate profit generation efficiency. Steady growth in the TTM net income per share confirms the success of the Chemed Corporation (CHE) strategy of reinvesting Roto-Rooter cash flows into the expansion of the VITAS hospice network amid the aging US population.
